罕见病药物氨己烯酸片用于治疗什么病

What diseases are rare disease drugs used to treat?

Vigabatrin, brand name Sabril, is a drug used to treat epilepsy and infantile spasms. It was developed in the 1980s. In 1989, vigabatrin tablets (vigabatrin) were approved for treatment in the UK. On August 21, 2009, the US FDA approved vigabatrin tablets (vigabatrin) as monotherapy for pediatric patients 1 month to 2 years old, where the potential benefits of infantile spasms outweigh the potential risk of vision loss, and as an adjuvant (additional) treatment (CPS) for adult patients with refractory complex partial epilepsy.

A generic version of vigabatrin tablets (vigabatrin, 500mg tablets) was launched in the United States. The drug was approved by the FDA in mid-January 2019 and is the first generic version of vigabatrin tablets (vigabatrin, vigabatrin tablets) to enter the US market.

Dosage and usage of vigabatrin tablets (vigabatrin): The use of vigabatrin tablets (vigabatrin) should be done under the guidance of an epilepsy expert or a child neurologist. Reactions after taking the medication should be reported to the doctor promptly.

Vigabatrin tablets (vigabatrin) are oral medications that can be taken once or twice a day, before or after meals. It is advisable to drink half a glass of water when taking the medication. If your epilepsy does not improve after taking it for a sufficient period of time, you should stop taking vigabatrin tablets. At this time, vigabatrin should be gradually stopped under the supervision of a doctor. Children younger than 6 years old are prone to choking when taking tablets, so please pay attention to this.

(Vigabatrin, vigabatrin) Adult dosage: The maximum dosage is 2-3 grams per day. It is appropriate to start taking it at 1g a day, and then according to the reaction after taking the medicine, if the reaction is good, it can be increased by 0.5g every week. Finally, the daily dosage is reached 2-3g. The maximum daily dosage should not exceed 3g. There is no inevitable connection between dosage and efficacy. During the treatment period, patients should not increase or decrease the dosage of drugs without authorization. Only correct use of drugs will help the condition.

Recommended hot articles: /newsDetail/82817.html